S. N. Rizvi

Molecular imaging for visualization and quantification of individualized targeted cancer therapy

M. Lubberink, O. Hoekstra, G. Dongen, 2010 .

Absolute Quantification of [C]docetaxel Kinetics in Lung Cancer Patients Using Positron Emission Tomography

Astrid A. M. van der Veldt, M. Lubberink, A. Lammertsma, 2011 .

Interacties en bijwerkingen van nonsteroidal anti-inflammatory drugs

J. Baart, R. Allard, S. N. Rizvi, 2010 .

Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin’s lymphoma using 89Zr-ibritumomab tiuxetan and PET

M. Lubberink, G. V. van Dongen, O. Hoekstra, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

18F-FDG or 3′-Deoxy-3′-18F-Fluorothymidine to Detect Transformation of Follicular Lymphoma

R. Boellaard, O. Hoekstra, P. M. van de Ven, 2015, The Journal of Nuclear Medicine.

Absolute Quantification of [11C]docetaxel Kinetics in Lung Cancer Patients Using Positron Emission Tomography

M. Lubberink, A. Lammertsma, R. Schuit, 2011, Clinical Cancer Research.

Two decades at the cross-roads of biology, physics and epidemiology: lessons learned in [18F-]FDG positron emission tomography in oncology.

R. Boellaard, O. Hoekstra, H. van Tinteren, 2010, European journal of cancer.

18 F-FDG or 3 9-Deoxy-3 9-18 F-Fluorothymidine to Detect Transformation of Follicular Lymphoma

R. Boellaard, O. Hoekstra, S. Zweegman, 2015 .

Two decades at the cross-roads of biology, physics and epidemiology: lessons learned in [18F-]FDG positron emission tomography in oncology.

R. Boellaard, O. Hoekstra, H. van Tinteren, 2010, European journal of cancer.